全球化BD合作，将打开高价值海外蓝海。作为全球首款CIN2非手术治疗产品，APL-1702的国际多中心Ⅲ期临床数据已发表于Cell Press旗下《Med》杂志，疗效和安全性得到全球医学界认可。目前，其上市许可申请已获欧洲药品管理局受理，并与FDA就美国上市的Ⅲ期临床设计达成一致，亚虹医药正积极寻找海外商业化合作伙伴，并与多家跨国药企保持密切沟通。
Justin RowlattClimate Editor。业内人士推荐搜狗输入法下载作为进阶阅读
20+ curated newsletters。业内人士推荐电影作为进阶阅读
He and his dad Shaun had been due to fly home through Doha but it was grounded.
국힘, 靑 앞서 의총…“李, 사법 악법 공포하면 역사 죄인될 것”